Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 20, 2020 - Issue 9
Submit an article Journal homepage
9,992
Views
21
CrossRef citations to date
0
Altmetric
Review

Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications

Subramanian Loganathana Clinical Sciences, Clinical Development and Medical Affairs, Biocon Biologics India Ltd, Bengaluru, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7186-0049View further author information
ORCID Icon,
Sandeep N. Athalyea Clinical Sciences, Clinical Development and Medical Affairs, Biocon Biologics India Ltd, Bengaluru, IndiaView further author information
&
Shashank R. Joshib Consultant, Joshi Clinic and Lilavati Hospital, Mumbai, IndiaView further author information
Pages 1025-1031 | Received 19 Jun 2020, Accepted 16 Jul 2020, Published online: 29 Jul 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.